DFine

San Jose, United States Founded: 2004 • Age: 22 yrs Acquired By Merit
Minimally invasive devices for vertebral compression fractures are developed.

About DFine

DFine is a Healthcare company based in San Jose (United States) founded in 2004, and was acquired by Merit in July 2016. Minimally invasive devices for vertebral compression fractures are developed. DFine has raised $125.95 million across 8 funding rounds from investors including Merit Medical, Orbimed and Prospect Venture Partners. The company was acqui-hired. DFine offers products and services including Arcadia™ Balloon Catheter, StabiliT® MX, StabiliT® VP, Osseoflex® SB, and STAR™ Tumor Ablation System. Its focus areas include Life Sciences, Orthopedics, Medical Devices and Therapies. Its legal entity is MERIT MEDICAL SYSTEMS, INC. Its competitors include Nevro, ATEC Spine and Vertos Medical; 2 of its 3 listed competitors have raised funding.

Company details

DFine was founded in 2004 in San Jose, United States, where minimally invasive medical devices are developed for treating vertebral compression fractures and metastatic spinal tumors. The Radiofrequency-Targeted Vertebral Augmentation system is utilized for fracture treatment, while the STAR Tumor Ablation System supports palliative care in cancer patients. Operations are conducted in the medical device sector, with additional offices located in Mannheim, Germany.

Operational Areas
Key Metrics
  • Total Equity Funding
    $125.95M (USD)

    in 8 rounds

  • Latest Funding Round
    $17.49M (USD), Series E

    Dec 2013

  • Investors
  • Acquired by
    Merit

    (Jul 2016)

Products & Services of DFine

DFine offers a comprehensive portfolio of products and services, including Arcadia™ Balloon Catheter, StabiliT® MX, StabiliT® VP, Osseoflex® SB, and STAR™ Tumor Ablation System.

Arcadia™ Balloon Catheter
Medical Device

Catheter for controlled cavity creation in vertebral procedures

StabiliT® MX
Vertebral Augmentation System

System for delivering high-viscosity cement in fractures

StabiliT® VP
Vertebroplasty System

Tool for controlled cement delivery in spine treatments

Osseoflex® SB
Bone Tamp

Device for creating cavities in vertebral compression fractures

STAR™ Tumor Ablation System
Ablation Technology

System for targeted radiofrequency tumor destruction

Apps and channels of DFine

its YouTube channel Merit Medical has 16.4K subscribers and 30 videos.

Merit Medical
YouTube 16.4K subscribers 30 videos Howto & Style
Open channel

Videos from DFine

The most watched videos on DFine's YouTube channel, Merit Medical (16.4K subscribers). Click a video to play it here.

Introducing the Surfacer® Inside-Out® Access Catheter System
5.6K views
SafeGuard Focus™ & SafeGuard Focus Cool™ [ in-service]
2.6K views
Prelude Roadster™ guide sheath [in-service]
2K views
SCOUT® Radar Localization Customer Experience with Dr. Reid
566 views

More on Merit Medical.

Funding Insights of DFine

DFine has successfully raised a total of $125.95M across 8 strategic funding rounds. The most recent funding activity was a Series E round of $17.49 million completed in December 2013. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $125.95M
  • Total Rounds 8
  • Last Round Series E — $17.49M
  • First Round $249,999

    (Jul 2005)

  • Investors Count 6

All 8 funding rounds of DFine with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Dec 2013$17.49MSeries E––
–
Oct 2011$14.98MSeries D–Orbimed, Prospect Venture Partners
–
Jul 2010$36.2MSeries D–Split Rock Partners, Orbimed
Mar 2010$5.82MSeries C–Prospect Venture Partners, Vanguard Ventures
–
Jan 2009$34.78MSeries C–Vanguard Ventures, BB&T
Feb 2007$9.39MSeries B––
–
Jan 2006$7.03MSeries A–Prospect Venture Partners
–
Jul 2005$249,999Seed––
–
Valuation history

7 investors in total: 7 institutional.

Investors in DFine

DFine has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include Merit Medical, Orbimed and Prospect Venture Partners.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Investments are made by OrbiMed in global healthcare innovations across biopharmaceuticals and related fields.
1989orbimed.comNew York, United States
Investments are made in US life sciences and healthtech firms.
prospectventures.comPalo Alto, United States
US venture capital investments are made across all stages.
splitrock.comEden Prairie, United States
vanguardventures.com
Investment management services are offered by Highland Capital.
highlandcapital.com
bbt.com
Medical devices for cardiology and radiology procedures are manufactured.
1987merit.comSouth Jordan, United States
Premium access

Investor details for DFine

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of DFine

4 dated milestones of DFine across 12 years, from founding to its latest funding, stage changes and deals.

  1. Founded DFine is founded.
  2. Funding First funding round of $250K.
  3. Funding Latest funding round, Series E, of $17.5M.
  4. Exit Acquired by Merit.

Competitors of DFine

DFine has 3 listed competitors in our database, 2 of them funded. They include Nevro, ATEC Spine and Vertos Medical.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
nevro.com2006Menlo Park, United States$154.1M1,215
Provider of high-frequency spinal cord stimulation implants
atecspine.com1990San Diego, United States839
Treatment solutions for spine disorders are developed.
vertosmed.com2005Aliso Viejo, United States$177.75M140
Minimally invasive treatments for lumbar spinal stenosis are developed.
Premium access

Detailed competitors of DFine

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of DFine

Websites that share an audience with DFine (dfineinc.com).

Similar websites

Websites whose visitors overlap most with DFine. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
nuvasive.com
100%
122.8K#333,205View details
aqueductmedical.com
aqueductmedical.com
96%
–
carefusion.com
69%
5.9K#3,234,823View details

Top companies in Orthopedics

3 companies that operate in the same segment as DFine (Orthopedics) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Provider of high-frequency spinal cord stimulation implants
2006Menlo Park, California, United StatesUSD 154.1 MUSD 353.08 M1,215
Developer of therapies for the treatment of musculoskeletal disorders
2007Woburn, Massachusetts, United StatesUSD 62 MUSD 85.55 M692
Antibody-siRNA complexes are developed for cancer treatment.
2012San Diego, California, United StatesUSD 142.54 MUSD 10.9 M391
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • âś“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • âś“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • âś“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Dfine

Premium access

Complete news archive for DFine

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about DFine

DFine was founded in 2004 and raised its 1st funding round 1 year after it was founded.

DFine is headquartered in San Jose, United States. It is registered at San Jose, California, United States.

DFine is a funded company, having raised a total of $125.95M across 8 funding rounds to date. The company's 1st funding round was a Seed of $250K, raised on Jul 2005.

DFine was founded in 2004 in San Jose, United States, where minimally invasive medical devices are developed for treating vertebral compression fractures and metastatic spinal tumors. The Radiofrequency-Targeted Vertebral Augmentation system is utilized for fracture treatment, while the STAR Tumor Ablation System supports palliative care in cancer patients. Operations are conducted in the medical device sector, with additional offices located in Mannheim, Germany.

DFine's top competitors include Nevro, ATEC Spine and Vertos Medical.

DFine offers Arcadia™ Balloon Catheter, StabiliT® MX, StabiliT® VP, Osseoflex® SB, and STAR™ Tumor Ablation System.

DFine has 7 investors. Key investors include Merit Medical, Orbimed, Prospect Venture Partners, Split Rock Partners, and Vanguard Ventures.

DFine operates through Merit Medical Systems, Inc..

Yes. DFine was acquired by Merit in July 2016.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available